User profiles for R. Fredslund Andersen
Rikke Fredslund AndersenVerified email at rsyd.dk Cited by 3983 |
International interlaboratory digital PCR study demonstrating high reproducibility for the measurement of a rare sequence variant
…, F Fina, T Forshew, R Fredslund Andersen… - Analytical …, 2017 - ACS Publications
This study tested the claim that digital PCR (dPCR) can offer highly reproducible quantitative
measurements in disparate laboratories. Twenty-one laboratories measured four blinded …
measurements in disparate laboratories. Twenty-one laboratories measured four blinded …
Protein levels and gene expressions of the epidermal growth factor receptors, HER1, HER2, HER3 and HER4 in benign and malignant ovarian tumors
…, R Fredslund Andersen… - International …, 2008 - spandidos-publications.com
… Baekelandt M, Kristensen GB, Trope CG, Nesland JM and Holm R: Epidermal growth factor
receptor expression has no independent prognostic significance in advanced ovarian cancer…
receptor expression has no independent prognostic significance in advanced ovarian cancer…
Reporting on circulating tumor DNA monitoring in metastatic cancer—From clinical validity to clinical utility
…, M Støchkel Frank, R Fredslund Andersen… - Cancer, 2022 - Wiley Online Library
This commentary attempts to discuss the required standardization of circulating tumor DNA
(ctDNA) analyses and thereby improve the clinical validity of ctDNA monitoring in the …
(ctDNA) analyses and thereby improve the clinical validity of ctDNA monitoring in the …
[HTML][HTML] Circulating free DNA as biomarker and source for mutation detection in metastatic colorectal cancer
KLG Spindler, N Pallisgaard, RF Andersen… - PloS one, 2015 - journals.plos.org
Background Circulating cell-free DNA (cfDNA) in plasma has shown potential as biomarker
in various cancers and could become an importance source for tumour mutation detection. …
in various cancers and could become an importance source for tumour mutation detection. …
The prognostic value of KRAS mutated plasma DNA in advanced non-small cell lung cancer
…, KLG Spindler, N Pallisgaard, RF Andersen… - Lung cancer, 2013 - Elsevier
BACKGROUND: Lung cancer is one of the most common malignant diseases worldwide and
associated with considerable morbidity and mortality. New agents targeting the epidermal …
associated with considerable morbidity and mortality. New agents targeting the epidermal …
Changes in mutational status during third‐line treatment for metastatic colorectal cancer—Results of consecutive measurement of cell free DNA, KRAS and BRAF in …
…, N Pallisgaard, RF Andersen… - … journal of cancer, 2014 - Wiley Online Library
KRAS and BRAF mutations are responsible for primary resistance to epidermal growth factor
receptor (EGFR) MoAbs in metastatic colorectal cancer (mCRC), but it is unknown what …
receptor (EGFR) MoAbs in metastatic colorectal cancer (mCRC), but it is unknown what …
[HTML][HTML] Quantification of microRNA levels in plasma–impact of preanalytical and analytical conditions
Numerous studies have reported a potential role for circulating microRNAs as biomarkers in
a wide variety of diseases. However, there is a critical reproducibility challenge some of …
a wide variety of diseases. However, there is a critical reproducibility challenge some of …
Controls to validate plasma samples for cell free DNA quantification
N Pallisgaard, KLG Spindler, RF Andersen… - Clinica Chimica …, 2015 - Elsevier
Recent research has focused on the utility of cell free DNA (cfDNA) in serum and plasma for
clinical application, especially in oncology. The literature holds promise of cfDNA as a …
clinical application, especially in oncology. The literature holds promise of cfDNA as a …
[HTML][HTML] Delta tocotrienol in recurrent ovarian cancer. A phase II trial
CB Thomsen, RF Andersen, KD Steffensen… - Pharmacological …, 2019 - Elsevier
Delta tocotrienol has anti-neoplastic activity as demonstrated in several in-vitro and in-vivo
investigations. The effect relies on inhibition of different pathways. It also has antiangiogenic …
investigations. The effect relies on inhibition of different pathways. It also has antiangiogenic …
[HTML][HTML] Clinical utility of KRAS status in circulating plasma DNA compared to archival tumour tissue from patients with metastatic colorectal cancer treated with anti …
…, N Pallisgaard, AL Appelt, RF Andersen… - European journal of …, 2015 - Elsevier
… Author links open overlay panel Karen-Lise Garm Spindler a c , Niels Pallisgaard b , Ane
Lindegaard Appelt c , Rikke Fredslund Andersen b , Jakob V. Schou d , Dorte Nielsen d g , Per …
Lindegaard Appelt c , Rikke Fredslund Andersen b , Jakob V. Schou d , Dorte Nielsen d g , Per …